Mibet Kiwi
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Mibet Kiwi

View Profile

Base

Bio

Mibet là một thương hiệu giải trí trực tuyến nổi bật với nhiều năm kinh nghiệm trên thị trường, chuyên cung cấp các sản phẩm cá cược chất lượng và minh bạch. 

Địa chỉ: 498 Đường Dương Bá Trạc, Phường 1, quận 8, Thành phố Hồ Chí Minh, 700000, Vietnam. 

Phone: 0988 494 797. 

Email: mibet.kiwi@gmail.com.

 Website: https://mibet.kiwi/ 

#mibet #trangchumibet #dangkymibet #dangnhapmibet #linkmibet

Các MXH tham gia : 

https://www.facebook.com/mibetkiwi/

https://x.com/mibetkiwi

https://www.pinterest.com/mibetkiwi/

https://vimeo.com/mibetkiwi

https://gravatar.com/mibetkiwi

https://profile.hatena.ne.jp/mibetkiwi/

https://mibetkiwi.readthedocs.io/

 
Display Name

Mibet Kiwi
I am

the patient
Initial Diagnosis Month

April
Initial Diagnosis Year

1994
Stage at Diagnosis

Stage 2
Current Stage

Stage 4
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics